相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum 2-Hydroxyglutarate Production in IDH1- and IDH2-Mutated De Novo Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group
Maxime Janin et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma
Barbara Meissner et al.
BLOOD (2013)
Clonal architecture of chronic myelomonocytic leukemias
Raphael Itzykson et al.
BLOOD (2013)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
Genome-wide Analysis Reveals TET- and TDG-Dependent 5-Methylcytosine Oxidation Dynamics
Li Shen et al.
CELL (2013)
Influence of Metabolism on Epigenetics and Disease
William G. Kaelin et al.
CELL (2013)
Dynamic Readers for 5-(Hydroxy)Methylcytosine and Its Oxidized Derivatives
Cornelia G. Spruijt et al.
CELL (2013)
The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation
Su Jung Song et al.
CELL STEM CELL (2013)
Combined Deficiency of Tet1 and Tet2 Causes Epigenetic Abnormalities but Is Compatible with Postnatal Development
Meelad M. Dawlaty et al.
DEVELOPMENTAL CELL (2013)
TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS
Rachel Deplus et al.
EMBO JOURNAL (2013)
Somatic Alterations Contributing to Metastasis of a Castration-Resistant Prostate Cancer
Michael L. Nickerson et al.
HUMAN MUTATION (2013)
Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia
Steven M. Chan et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Hydroquinone Increases 5-Hydroxymethylcytosine Formation through Ten Eleven Translocation 1 (TET1) 5-Methylcytosine Dioxygenase
Jonathan B. Coulter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Isocitrate dehydrogenase mutations in leukemia
Anna Sophia McKenney et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Raphael Itzykson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Notch pathway activation targets AML-initiating cell homeostasis and differentiation
Camille Lobry et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Ascorbic Acid Enhances Tet-Mediated 5-Methylcytosine Oxidation and Promotes DNA Demethylation in Mammals
Ruichuan Yin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Oct4 and the small molecule inhibitor, SC1, regulates Tet2 expression in mouse embryonic stem cells
Yongyan Wu et al.
MOLECULAR BIOLOGY REPORTS (2013)
Different Roles for Tet1 and Tet2 Proteins in Reprogramming-Mediated Erasure of Imprints Induced by EGC Fusion
Francesco M. Piccolo et al.
MOLECULAR CELL (2013)
Tet Proteins Connect the O-Linked N-acetylglucosamine Transferase Ogt to Chromatin in Embryonic Stem Cells
Pietro Vella et al.
MOLECULAR CELL (2013)
Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l
L. Chen et al.
LEUKEMIA (2013)
An evolutionary perspective on chronic myelomonocytic leukemia
R. Itzykson et al.
LEUKEMIA (2013)
Mutations and prognosis in primary myelofibrosis
A. M. Vannucchi et al.
LEUKEMIA (2013)
TET2 promotes histone O-GlcNAcylation during gene transcription
Qiang Chen et al.
NATURE (2013)
Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells
Kathryn Blaschke et al.
NATURE (2013)
NANOG-dependent function of TET1 and TET2 in establishment of pluripotency
Yael Costa et al.
NATURE (2013)
Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX
Myunggon Ko et al.
NATURE (2013)
Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency
Tao Wang et al.
NATURE CELL BIOLOGY (2013)
Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia
Hirotoshi Sakaguchi et al.
NATURE GENETICS (2013)
Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma
Thilo Gambichler et al.
MELANOMA RESEARCH (2013)
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
H. Yang et al.
ONCOGENE (2013)
(R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
Julie-Aurore Losman et al.
SCIENCE (2013)
Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
Fang Wang et al.
SCIENCE (2013)
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2
Paul Guilhamon et al.
NATURE COMMUNICATIONS (2013)
5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes
Maja Klug et al.
GENOME BIOLOGY (2013)
The Curious Chemical Biology of Cytosine: Deamination, Methylation,and Oxidation as Modulators of Genomic Potential
Christopher S. Nabel et al.
ACS CHEMICAL BIOLOGY (2012)
In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells
Erinn Soucie et al.
BLOOD (2012)
Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters
Francois Lemonnier et al.
BLOOD (2012)
IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma
Rob A. Cairns et al.
BLOOD (2012)
ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
Omar Abdel-Wahab et al.
CANCER CELL (2012)
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
Christine Guo Lian et al.
CELL (2012)
MeCP2 Binds to 5hmC Enriched within Active Genes and Accessible Chromatin in the Nervous System
Marian Mellen et al.
CELL (2012)
Tet3 CXXC Domain and Dioxygenase Activity Cooperatively Regulate Key Genes for Xenopus Eye and Neural Development
Yufei Xu et al.
CELL (2012)
DNA methylation: TET proteins-guardians of CpG islands?
Kristine Williams et al.
EMBO REPORTS (2012)
Tet2 Facilitates the Derepression of Myeloid Target Genes during CEBPα-Induced Transdifferentiation of Pre-B Cells
Eric M. Kallin et al.
MOLECULAR CELL (2012)
Landscape of TET2 mutations in acute myeloid leukemia
S. Weissmann et al.
LEUKEMIA (2012)
Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2
Claudia A. Doege et al.
NATURE (2012)
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu et al.
NATURE (2012)
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Peppi Koivunen et al.
NATURE (2012)
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
Lambert Busque et al.
NATURE GENETICS (2012)
Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation
John A. Hanover et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
TET2 and DNMT3A Mutations in Human T-Cell Lymphoma
Lucile Couronne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Activation-Induced Cytidine Deaminase Alters the Subcellular Localization of Tet Family Proteins
Yuko Arioka et al.
PLOS ONE (2012)
Hydroxylation of 5-methylcytosine by TET2 maintains the active state of the mammalian HOXA cluster
Michael T. Bocker et al.
NATURE COMMUNICATIONS (2012)
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A
Anna M. Jankowska et al.
BLOOD (2011)
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial
Thorsten Braun et al.
BLOOD (2011)
Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors
Elodie Pronier et al.
BLOOD (2011)
Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
Zhe Li et al.
BLOOD (2011)
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
Wen-Chien Chou et al.
BLOOD (2011)
TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm
Fabrice Jardin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
Cyril Quivoron et al.
CANCER CELL (2011)
Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
Kelly Moran-Crusio et al.
CANCER CELL (2011)
Thymine DNA Glycosylase Is Essential for Active DNA Demethylation by Linked Deamination-Base Excision Repair
Salvatore Cortellino et al.
CELL (2011)
Mbd3/NURD Complex Regulates Expression of 5-Hydroxymethylcytosine Marked Genes in Embryonic Stem Cells
Ozlem Yildirim et al.
CELL (2011)
DNA Demethylation Dynamics
Nidhi Bhutani et al.
CELL (2011)
Emerging roles of TET proteins and 5-Hydroxymethylcytosines in active DNA demethylation and beyond
Junjie U. Guo et al.
CELL CYCLE (2011)
Tet1 Is Dispensable for Maintaining Pluripotency and Its Loss Is Compatible with Embryonic and Postnatal Development
Meelad M. Dawlaty et al.
CELL STEM CELL (2011)
Tet1 and Tet2 Regulate 5-Hydroxymethylcytosine Production and Cell Lineage Specification in Mouse Embryonic Stem Cells
Kian Peng Koh et al.
CELL STEM CELL (2011)
Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation
Hao Wu et al.
GENES & DEVELOPMENT (2011)
Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells
Hao Wu et al.
GENES & DEVELOPMENT (2011)
TET2 mutations in secondary acute myeloid leukemias: a French retrospective study
Olivier Kosmider et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Impact of TET2 mutations on mRNA expression and clinical outcomes in MDS patients treated with DNA methyltransferase inhibitors
Daniel A. Pollyea et al.
HEMATOLOGICAL ONCOLOGY (2011)
Thymine DNA Glycosylase Can Rapidly Excise 5-Formylcytosine and 5-Carboxylcytosine POTENTIAL IMPLICATIONS FOR ACTIVE DEMETHYLATION OF CpG SITES
Atanu Maiti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia
Romain Aucagne et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
Felicitas Thol et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
TET2 Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
Klaus H. Metzeler et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Genome-wide Regulation of 5hmC, 5mC, and Gene Expression by Tet1 Hydroxylase in Mouse Embryonic Stem Cells
Yufei Xu et al.
MOLECULAR CELL (2011)
Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia
C. Roche-Lestienne et al.
LEUKEMIA (2011)
Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance
V. Grossmann et al.
LEUKEMIA (2011)
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine
M. T. Voso et al.
LEUKEMIA (2011)
Genomic 5-hydroxymethylcytosine levels correlate with TET2 mutations and a distinct global gene expression pattern in secondary acute myeloid leukemia
N. Konstandin et al.
LEUKEMIA (2011)
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
R. Itzykson et al.
LEUKEMIA (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity
Kristine Williams et al.
NATURE (2011)
Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells
William A. Pastor et al.
NATURE (2011)
Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation
Gabriella Ficz et al.
NATURE (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Recognition of 5-Hydroxymethylcytosine by the Uhrf1 SRA Domain
Carina Frauer et al.
PLOS ONE (2011)
Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice
Myunggon Ko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
Yu-Fei He et al.
SCIENCE (2011)
Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine
Shinsuke Ito et al.
SCIENCE (2011)
Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm
Philip A. Beer et al.
BLOOD (2010)
Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms
Franz X. Schaub et al.
BLOOD (2010)
Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission
Olivier Nibourel et al.
BLOOD (2010)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
Maria E. Figueroa et al.
CANCER CELL (2010)
Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis
Johanna Flach et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1
Alexander Kohlmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
Guido Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
A. Tefferi et al.
LEUKEMIA (2010)
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
Myunggon Ko et al.
NATURE (2010)
Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification
Shinsuke Ito et al.
NATURE (2010)
Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis
Frederic Pendino et al.
BLOOD (2009)
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)
Olivier Kosmider et al.
BLOOD (2009)
Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates
A. Tefferi et al.
LEUKEMIA (2009)
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
A. Tefferi et al.
LEUKEMIA (2009)
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
A. Tefferi et al.
LEUKEMIA (2009)
Acquired mutations in TET2 are common in myelodysplastic syndromes
Saskia M. C. Langemeijer et al.
NATURE GENETICS (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling
T. Kojima et al.
ONCOGENE (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
Versatility of biological non-heme Fe(II) centers in oxygen activation reactions
Elena G. Kovaleva et al.
NATURE CHEMICAL BIOLOGY (2008)
TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)
RB Lorsbach et al.
LEUKEMIA (2003)
Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein
SI Hino et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
分享论文
